Exosome autoantibody biomarkers for detection of lung cancer.

Autor: Thuya WL; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore., Peyper JM; Sengenics Corporation, Jalan Kerinchi, Bangsar South, 59200, Kuala Lumpur, Malaysia.; University of Cape Town, Cape Town, 7700, South Africa., Myen TT; Sengenics Corporation, Jalan Kerinchi, Bangsar South, 59200, Kuala Lumpur, Malaysia., Anuar ND; Sengenics Corporation, Jalan Kerinchi, Bangsar South, 59200, Kuala Lumpur, Malaysia., Anwar A; Sengenics Corporation, Jalan Kerinchi, Bangsar South, 59200, Kuala Lumpur, Malaysia., Gudimella R; Sengenics Corporation, Jalan Kerinchi, Bangsar South, 59200, Kuala Lumpur, Malaysia., Rutt NH; Sengenics Corporation, Jalan Kerinchi, Bangsar South, 59200, Kuala Lumpur, Malaysia., Rosli NSM; Sengenics Corporation, Jalan Kerinchi, Bangsar South, 59200, Kuala Lumpur, Malaysia., Badri NH; Sengenics Corporation, Jalan Kerinchi, Bangsar South, 59200, Kuala Lumpur, Malaysia., Rahman TNA; Sengenics Corporation, Jalan Kerinchi, Bangsar South, 59200, Kuala Lumpur, Malaysia., Nurashirin R; Sengenics Corporation, Jalan Kerinchi, Bangsar South, 59200, Kuala Lumpur, Malaysia., Sethi G; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117600, Singapore.; NUS Centre for Cancer Research (N2CR), Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117599, Singapore., Tam JKC; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, 15 1E Kent Ridge Road, Singapore, 119228, Singapore., Wong AL; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore.; NUS Centre for Cancer Research (N2CR), Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117599, Singapore.; Department of Haematology-Oncology, National University Cancer Institute, National 17 University Health System, Singapore, 119228, Singapore., Soo R; Department of Haematology-Oncology, National University Cancer Institute, National 17 University Health System, Singapore, 119228, Singapore., Blackburn JM; Sengenics Corporation, Jalan Kerinchi, Bangsar South, 59200, Kuala Lumpur, Malaysia.; University of Cape Town, Cape Town, 7700, South Africa., Wang L; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore. csiwl@nus.edu.sg.; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117600, Singapore. csiwl@nus.edu.sg.; NUS Centre for Cancer Research (N2CR), Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117599, Singapore. csiwl@nus.edu.sg., Goh BC; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore. phcgbc@nus.edu.sg.; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117600, Singapore. phcgbc@nus.edu.sg.; NUS Centre for Cancer Research (N2CR), Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117599, Singapore. phcgbc@nus.edu.sg.; Department of Haematology-Oncology, National University Cancer Institute, National 17 University Health System, Singapore, 119228, Singapore. phcgbc@nus.edu.sg.

Publikováno v: Military Medical Research [Mil Med Res] 2024 Nov 18; Vol. 11 (1), pp. 72. Date of Electronic Publication: 2024 Nov 18.